Invivita D Injection (Cholecalciferol)

Adult administration

200,000 IU of cholecalciferol is administered via intramuscular injection. Annual dosing should not exceed 600,000 IU of cholecalciferol.

Child administration

200,000 IU of cholecalciferol is administered via intramuscular injection.

This medicine contains vitamin D, so it is important to check the total vitamin D content when taking it with vitamin D fortified foods or other vitamin D preparations. Calcium levels in the blood should be regularly checked, and the medication should be discontinued if calcium levels become too high. If calcium intake is high, it is important to frequently monitor calcium levels in the blood and urine. This medication should not be used in patients with certain diseases, those with poor kidney function, or women who are pregnant or breastfeeding. Various side effects such as headaches, muscle pain, gastrointestinal disturbances, dehydration, and hypertension may occur, so if any abnormal symptoms arise, consult a doctor immediately. When administering to patients with vitamin D deficiency, blood vitamin D levels should be periodically checked, and overdose should be avoided. Patients with impaired kidney function or the elderly should regularly undergo kidney function tests, and dosage adjustments should be made if necessary. As interactions with other drugs may occur, consult a doctor or pharmacist if taking anticonvulsants, diuretics, antacids, etc. together. During pregnancy, excessive intake of vitamin D can be harmful to the fetus, so it is safest not to use this medication. For children under 12 years of age, safety and efficacy have not been adequately confirmed, so it is recommended not to use this medication. In case of overdose, stop taking the medication immediately, reduce calcium intake, increase fluid intake, and treatment to promote diuresis may be necessary. This medication should not be mixed with other drugs, and once the ampoule is opened, it should be used quickly, and any remaining medication should be discarded. Store in a light-resistant, opaque sealed container and keep at a cool temperature between 1 and 25 degrees Celsius to maintain the effectiveness and safety of the medication.

Serious side effects

Hives due to hypersensitivity, kidney damage due to hypercalcemia, arrhythmias, hypercalciuria, hypercalcemia, tissue calcification of kidneys and blood vessels, excessive bone calcification

Mild side effects

Headaches, weakness, fatigue, muscle pain, loss of appetite, weight loss, growth retardation, nausea, vomiting, constipation, diarrhea, polydipsia, polyuria, dehydration, hypertension, calcium stones, tissue calcification of kidneys and blood vessels, excessive bone calcification, arrhythmia, psychiatric symptoms, perceptual disturbances, joint pain, myasthenia, drowsiness, azotemia, hypersensitivity reactions, thirst, confusion, bloating, abdominal pain, metallic taste, dry mouth, rash, itching, hyperphosphatemia, hyperphosphaturia,

This medication is sensitive to light, so it should be stored in a light-tight, opaque sealed container. Additionally, it is advisable to store the medication at a cool temperature between 1 and 25 degrees Celsius. This way of storage helps maintain the drug's efficacy and safety.

Appearance

A brown ampoule containing a colorless, transparent liquid with no odor and a light yellow color.

Package unit

1mL/ampoule X 10